Africa (WHO region) vs Malta: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Malta
100.0%
in 2023
Africa (WHO region) rank
2nd
Malta rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Malta
How they compare
Malta currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
Across all 8 years both countries report, Malta has been ahead every year.
Africa (WHO region) ranks 2nd and Malta ranks 1st of 11 groups.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.7% | 100.0% | 65.3% | Malta |
| 2010s | 85.5% | 100.0% | 14.5% | Malta |
| 2020s | 92.3% | 100.0% | 7.7% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Malta?
- Malta, at 100.0% against 96.0% in Africa (WHO region) as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Malta?
- 4.0%, with Malta ahead.
- How many years of comparable data are there for Africa (WHO region) and Malta?
- 8 years are reported by both, from 2006 to 2023.
- How do Africa (WHO region) and Malta rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Malta ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.